Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision making.

Claeys KC, Heil EL, Pogue JM, Lephart PR, Johnson JK.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):144-146. doi: 10.1016/j.diagmicrobio.2018.01.012. Epub 2018 Feb 2.

PMID:
29449043
2.

Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to "Old" Cephalosporins and/or to Penicillins.

Zaidenstein R, Miller A, Tal-Jasper R, Ofer-Friedman H, Sklarz M, Katz DE, Lazarovitch T, Lephart PR, Mengesha B, Tzuman O, Dadon M, Daniel C, Moran-Gilad J, Marchaim D.

Microorganisms. 2018 Jan 16;6(1). pii: E9. doi: 10.3390/microorganisms6010009.

3.

Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258.

Dhar S, Martin ET, Lephart PR, McRoberts JP, Chopra T, Burger TT, Tal-Jasper R, Hayakawa K, Ofer-Friedman H, Lazarovitch T, Zaidenstein R, Perez F, Bonomo RA, Kaye KS, Marchaim D.

Open Forum Infect Dis. 2016 Feb 12;3(1):ofv213. doi: 10.1093/ofid/ofv213. eCollection 2016 Jan.

4.

Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial.

Salimnia H, Fairfax MR, Lephart PR, Schreckenberger P, DesJarlais SM, Johnson JK, Robinson G, Carroll KC, Greer A, Morgan M, Chan R, Loeffelholz M, Valencia-Shelton F, Jenkins S, Schuetz AN, Daly JA, Barney T, Hemmert A, Kanack KJ.

J Clin Microbiol. 2016 Mar;54(3):687-98. doi: 10.1128/JCM.01679-15. Epub 2016 Jan 6.

5.

The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive Analysis.

Lazarovitch T, Amity K, Coyle JR, Ackerman B, Tal-Jasper R, Ofer-Friedman H, Hayakawa K, Bogan C, Lephart PR, Kaplansky T, Maskit M, Azouri T, Zaidenstein R, Perez F, Bonomo RA, Kaye KS, Marchaim D.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1283-91. doi: 10.1017/ice.2015.186. Epub 2015 Sep 24.

PMID:
26399907
6.

Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.

Abdelhamed AM, Zhang SX, Watkins T, Morgan MA, Wu F, Buckner RJ, Fuller DD, Davis TE, Salimnia H, Fairfax MR, Lephart PR, Poulter MD, Regi SB, Jacobs MR.

J Clin Microbiol. 2015 May;53(5):1672-6. doi: 10.1128/JCM.00549-15. Epub 2015 Mar 11.

7.

Weissella confusa: problems with identification of an opportunistic pathogen that has been found in fermented foods and proposed as a probiotic.

Fairfax MR, Lephart PR, Salimnia H.

Front Microbiol. 2014 Jun 12;5:254. doi: 10.3389/fmicb.2014.00254. eCollection 2014.

8.

Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis.

Bogan C, Kaye KS, Chopra T, Hayakawa K, Pogue JM, Lephart PR, Bheemreddy S, Lazarovitch T, Zaidenstein R, Perez F, Bonomo RA, Marchaim D.

Am J Infect Control. 2014 Jun;42(6):612-20. doi: 10.1016/j.ajic.2014.02.013.

PMID:
24837111
9.

Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.

Hayakawa K, Martin ET, Gudur UM, Marchaim D, Dalle D, Alshabani K, Muppavarapu KS, Jaydev F, Bathina P, Sundaragiri PR, Rajuri SD, Khatri J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS.

Antimicrob Agents Chemother. 2014 Jul;58(7):3968-75. doi: 10.1128/AAC.02943-14. Epub 2014 May 5.

10.

Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.

Bhargava A, Hayakawa K, Silverman E, Haider S, Alluri KC, Datla S, Diviti S, Kuchipudi V, Muppavarapu KS, Lephart PR, Marchaim D, Kaye KS.

Infect Control Hosp Epidemiol. 2014 Apr;35(4):398-405. doi: 10.1086/675614.

PMID:
24602945
11.

Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.

Marchaim D, Pogue JM, Tzuman O, Hayakawa K, Lephart PR, Salimnia H, Painter T, Zervos MJ, Johnson LE, Perri MB, Hartman P, Thyagarajan RV, Major S, Goodell M, Fakih MG, Washer LL, Newton DW, Malani AN, Wholehan JM, Mody L, Kaye KS.

J Clin Microbiol. 2014 May;52(5):1617-21. doi: 10.1128/JCM.00001-14. Epub 2014 Mar 5.

12.

Surgical site infections in genital reconstruction surgery for gender reassignment, Detroit: 1984-2008.

Zhao JJ, Marchaim D, Palla MB, Bogan CW, Hayakawa K, Tansek R, Moshos J, Muthusamy A, Kotra H, Lephart PR, Wilson AN, Kaye KS.

Surg Infect (Larchmt). 2014 Apr;15(2):99-104. doi: 10.1089/sur.2012.225. Epub 2013 Nov 4.

13.

Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation.

Patel D, Marchaim D, Marcus G, Gayathri R, Lephart PR, Lazarovitch T, Zaidenstein R, Chandrasekar P.

Clin Transplant. 2014 Jan;28(1):1-5. doi: 10.1111/ctr.12227. Epub 2013 Sep 6. No abstract available.

PMID:
24033498
14.

Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.

Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS.

Antimicrob Agents Chemother. 2013 Aug;57(8):4010-8. doi: 10.1128/AAC.02516-12. Epub 2013 Jun 10.

15.

Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.

Pogue JM, Marchaim D, Abreu-Lanfranco O, Sunkara B, Mynatt RP, Zhao JJ, Bheemreddy S, Hayakawa K, Martin ET, Dhar S, Kaye KS, Lephart PR.

J Antibiot (Tokyo). 2013 Oct;66(10):625-7. doi: 10.1038/ja.2013.56. Epub 2013 May 29. No abstract available.

PMID:
23715037
16.

Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.

Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS.

Ann Pharmacother. 2012 Dec;46(12):1587-97. doi: 10.1345/aph.1R211. Epub 2012 Dec 4.

PMID:
23212935
17.

Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.

Hayakawa K, Marchaim D, Pogue JM, Ho K, Parveen S, Nanjireddy P, Sunkara B, Singla M, Jagadeesh KK, Moshos JA, Bommarito S, Mroue R, Farhat M, Obeid T, Chaudhry A, Vadlamudi G, Lephart PR, Martin ET, Rybak MJ, Kaye KS.

Am J Infect Control. 2012 Dec;40(10):e261-3. doi: 10.1016/j.ajic.2012.06.009.

PMID:
23199727
18.

Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.

Judge T, Pogue JM, Marchaim D, Ho K, Kamatam S, Parveen S, Tiwari N, Nanjireddy P, Bheemreddy S, Biedron C, Reddy SM, Khammam V, Chalana IK, Tumma RS, Collins V, Yousuf A, Lephart PR, Martin ET, Rybak MJ, Kaye KS, Hayakawa K.

Infect Control Hosp Epidemiol. 2012 Dec;33(12):1250-4. doi: 10.1086/668438. Epub 2012 Oct 25.

PMID:
23143365
19.

Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.

Hayakawa K, Marchaim D, Palla M, Gudur UM, Pulluru H, Bathina P, Alshabani K, Govindavarjhulla A, Mallad A, Abbadi DR, Chowdary D, Kakarlapudi H, Guddati H, Das M, Kannekanti N, Vemuri P, Doddamani R, Mundra VR, Guddeti RR, Policherla R, Bai S, Lohithaswa S, Shashidharan SP, Chidurala S, Diviti S, Sukayogula K, Joseph M, Pogue JM, Lephart PR, Martin ET, Rybak MJ, Kaye KS.

Antimicrob Agents Chemother. 2013 Jan;57(1):49-55. doi: 10.1128/AAC.01271-12. Epub 2012 Oct 15.

20.

The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.

Martin ET, Tansek R, Collins V, Hayakawa K, Abreu-Lanfranco O, Chopra T, Lephart PR, Pogue JM, Kaye KS, Marchaim D.

Am J Infect Control. 2013 Feb;41(2):180-2. doi: 10.1016/j.ajic.2012.02.036. Epub 2012 Aug 30.

PMID:
22939417
21.

The relationship between the new taxonomy of Streptococcus bovis and its clonality to colon cancer, endocarditis, and biliary disease.

Lazarovitch T, Shango M, Levine M, Brusovansky R, Akins R, Hayakawa K, Lephart PR, Sobel JD, Kaye KS, Marchaim D.

Infection. 2013 Apr;41(2):329-37. doi: 10.1007/s15010-012-0314-x. Epub 2012 Aug 11.

PMID:
22886774
22.

Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests.

Marchaim D, Sunkara B, Lephart PR, Gudur UM, Bhargava A, Mynatt RP, Zhao JJ, Bheemreddy S, Hayakawa K, Chopra T, Dhar S, Kaye KS.

Infect Control Hosp Epidemiol. 2012 Aug;33(8):853-5. doi: 10.1086/666632. Epub 2012 Jun 11. No abstract available.

PMID:
22759556
23.

Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.

Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, Pogue JM, Bheemreddy S, Blunden C, Shango M, Swan J, Lephart PR, Perez F, Bonomo RA, Kaye KS.

Infect Control Hosp Epidemiol. 2012 Aug;33(8):817-30. doi: 10.1086/666642. Epub 2012 Jun 11.

24.

Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.

Ku K, Pogue JM, Moshos J, Bheemreddy S, Wang Y, Bhargava A, Campbell M, Khandker N, Lephart PR, Chopra T, Hayakawa K, Martin ET, Abreu-Lanfranco O, Dhar S, Kaye KS, Marchaim D.

Am J Infect Control. 2012 Dec;40(10):983-7. doi: 10.1016/j.ajic.2011.12.014. Epub 2012 Mar 21.

PMID:
22440526
25.

Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.

Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee DW, Kamatam S, Bathina P, Nanjireddy P, Chalana IK, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS.

Antimicrob Agents Chemother. 2012 May;56(5):2452-8. doi: 10.1128/AAC.06299-11. Epub 2012 Feb 21.

26.

"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.

Marchaim D, Perez F, Lee J, Bheemreddy S, Hujer AM, Rudin S, Hayakawa K, Lephart PR, Blunden C, Shango M, Campbell ML, Varkey J, Manickam P, Patel D, Pogue JM, Chopra T, Martin ET, Dhar S, Bonomo RA, Kaye KS.

Am J Infect Control. 2012 Nov;40(9):830-5. doi: 10.1016/j.ajic.2011.10.013. Epub 2012 Feb 10.

27.

Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.

Collins VL, Marchaim D, Pogue JM, Moshos J, Bheemreddy S, Sunkara B, Shallal A, Chugh N, Eiseler S, Bhargava P, Blunden C, Lephart PR, Memon BI, Hayakawa K, Abreu-Lanfranco O, Chopra T, Munoz-Price LS, Carmeli Y, Kaye KS.

Antimicrob Agents Chemother. 2012 Apr;56(4):2173-7. doi: 10.1128/AAC.05913-11. Epub 2012 Jan 30.

28.

The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities.

Marchaim D, Chopra T, Bogan C, Bheemreddy S, Sengstock D, Jagarlamudi R, Malani A, Lemanek L, Moshos J, Lephart PR, Ku K, Hasan A, Lee J, Khandker N, Blunden C, Geffert SF, Moody M, Hiro R, Wang Y, Ahmad F, Mohammadi T, Faruque O, Patel D, Pogue JM, Hayakawa K, Dhar S, Kaye KS.

Am J Infect Control. 2012 Oct;40(8):760-5. doi: 10.1016/j.ajic.2011.09.011. Epub 2012 Jan 30.

PMID:
22285709
29.

Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression.

Sunkara B, Bheemreddy S, Lorber B, Lephart PR, Hayakawa K, Sobel JD, Kaye KS, Marchaim D.

Int J Infect Dis. 2012 Mar;16(3):e182-6. doi: 10.1016/j.ijid.2011.11.008. Epub 2012 Jan 10.

30.

Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens.

Marchaim D, Taylor AR, Hayakawa K, Bheemreddy S, Sunkara B, Moshos J, Chopra T, Abreu-Lanfranco O, Martin ET, Pogue JM, Lephart PR, Panda S, Dhar S, Kaye KS.

Am J Infect Control. 2012 Aug;40(6):562-4. doi: 10.1016/j.ajic.2011.07.014. Epub 2011 Dec 16.

PMID:
22177667
31.

Aerosolized vaccine as an unexpected source of false-positive Bordetella pertussis PCR results.

Salimnia H, Lephart PR, Asmar BI, Prebelich D, Paulson E, Fairfax MR.

J Clin Microbiol. 2012 Feb;50(2):472-4. doi: 10.1128/JCM.01250-11. Epub 2011 Dec 7.

32.

Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit.

Fairfax MR, Queenan AM, Lephart PR, Kaye KS, Dror M, Arnous N, Salimnia TT, Mitchell RA, Alangaden G, Salimnia H.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):325-6. doi: 10.1016/j.diagmicrobio.2011.06.007. Epub 2011 Aug 15. No abstract available.

PMID:
21840669
33.

Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.

Marchaim D, Chopra T, Perez F, Hayakawa K, Lephart PR, Bheemreddy S, Blunden C, Hujer AM, Rudin S, Shango M, Campbell M, Varkey J, Slim J, Ahmad F, Patel D, Chen TY, Pogue JM, Salimnia H, Dhar S, Bonomo RA, Kaye KS.

Infect Control Hosp Epidemiol. 2011 Sep;32(9):861-71. doi: 10.1086/661597.

34.

Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.

Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, Endimiani A, Navon-Venezia S, Hothi J, Slim J, Blunden C, Shango M, Lephart PR, Salimnia H, Reid D, Moshos J, Hafeez W, Bheemreddy S, Chen TY, Dhar S, Bonomo RA, Kaye KS.

Antimicrob Agents Chemother. 2011 Feb;55(2):593-9. doi: 10.1128/AAC.01020-10. Epub 2010 Nov 29.

35.

Listeria grayi: vancomycin-resistant, gram-positive rod causing bacteremia in a stem cell transplant recipient.

Salimnia H, Patel D, Lephart PR, Fairfax MR, Chandrasekar PH.

Transpl Infect Dis. 2010 Dec;12(6):526-8. doi: 10.1111/j.1399-3062.2010.00539.x.

PMID:
20626713
36.

Effect of the major repeat sequence on mitotic recombination in Candida albicans.

Lephart PR, Magee PT.

Genetics. 2006 Dec;174(4):1737-44. Epub 2006 Oct 8.

37.

Effect of the major repeat sequence on chromosome loss in Candida albicans.

Lephart PR, Chibana H, Magee PT.

Eukaryot Cell. 2005 Apr;4(4):733-41.

Supplemental Content

Loading ...
Support Center